None listed
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) patient group ? step 1: adult with over 18-year-old, patients who confirmed of acute leukemia by WHO classification, patients who can be checked the electronic medical record ? step 2: adult with over 18-year-old, patients who suspected of acute leukemiaL, and then confirmed with bone marrow apsirate by WHO classification, Patients with voluntary informed consent about blood and bone marrow sampling. 2) healthy donor group : among the all hematopoietic stem cell donors, healthy donor who donated with bone marrow cells
Exclusion criteria
Exclusion criteria: patients who not finally confirmed of acute leukemia by WHO classification
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Characteristics of patient and leukemia at diagnosis, type of chemotherapy, chemotherapy response, hematopoietic stem cell transplantation and related-survival rate, incidence of HSCT-related complications | — |
Secondary
| Measure | Time frame |
|---|---|
| Promising biomarker determination | — |
Countries
Korea, Republic of
Contacts
The Catholic University of Korea